PF-05280014

Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Wed, 11/30/16 - 09:44 pm
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer